Drug Topics - January 2009 - (Page 18) GREATER PATIENT INTERACTION Up front In Depth Pharmacy exclusively for diabetic patients opens in California ALAINA SCOTT, Senior Editor 18 DRUG TOPICS Januar y 2009 W W W.D R U GTO P I C S .C O M COURTESY A1C RX PHARMACY services to diabetics only. housands of Americans Several doctors and speare diagnosed with dicialists in the area have alabetes each year. Miready begun referring diachael Bosse, PharmD, CEO betic patients to the new and founder of a new pharpharmacy. Chris K. Guerin, macy called A1c Rx, wanted MD, of Tri-City Endocrinolto help diabetics take control ogy and Metabolism, said of their conditions. So he he first heard about the started one of the first pharpharmacy when it was in macies to serve an exclusively the planning stages. diabetic clientele. “I think there is a need “This has been brewing for this type of model,” for about two years,” Bosse Guerin said. “Diabetes said. “One of the things we management is becoming saw with the diabetic popuA1c Rx staff members meet with patients for approximately more complicated and is lation is a frequently compli45 minutes to educate them about their condition. constantly changing. This is cated pill regimen, injection due to technology and imschedule, testing schedules, At the clinical site, patients bring proved and varied pharmacological and things like that.” Bosse and other pharmacists decid- in all their medications, supplements, tools. I think this concept has a lot of ed to create a model for this difficult- herbal products, etc., Bosse said. The benefits for patients.” Janice Baker, RD, CDE, said she to-treat population. “Diabetes educa- pharmacist performs medication retors and doctors can offer great tips views, evaluating everything the refers patients to the pharmacy beand education. But the typical outpa- customers are using. A1c Rx then cause of the level of education it tient pharmacy doesn’t have time for supplies patients with all of their pre- provides. She added that it’s also iman extended visit with a pharmacist,” scription medications. The pharmacy portant that doctors, specialists, and delivers all medications and testing pharmacists work together to help he said. patients with illnesses such as diaBosse opened two A1c Rx sites in supplies to each patient’s home. “Customers love they have a phar- betes fully understand the condition. October. The pharmacy, in Carlsbad, Calif., works directly with prescribers macist they can talk to,” Bosse said. “Diabetes is a complicated disease, to provide personalized counseling, “We meet with these customers for and specialists are very important, testing supplies, and all medications, about 45 minutes. Patients can ask to make sure that this expensive including prescription medications, about prescription drugs, OTC side and devastating disease is well conOTC drugs, pharmacist-approved effects, usage, and whether they’re trolled,” she said. “We have a great opportunity to supplements, and other pharmacy taking everything the right way.” Bosse said he hasn’t heard of an- interact with these patients, to help items. The pharmacy sees patients by appointment only and has about eight other pharmacy using the same mod- them [manage] their disease,” Bosse patients per day. There is no retail el for patients, although he’s fairly said. “We can help them understand space; patients are seen at a clinical certain other versions of the concept why they’re taking these medications, service site. The second site handles exist. But the pharmacy is the only what those medications do, and how one in San Diego offering pharmacy to take them correctly.” processing and customer service. T http://WWW.DRUGTOPICS.COM
Table of Contents Feed for the Digital Edition of Drug Topics - January 2009 Drug Topics - January 2009 Contents Letters Up Front Up Front in Depth Community Practice Drug Pipeline: What to Watch in 2009 OTC Community-Aquired MRSA Infections New Products Viewpoint Drug Topics - January 2009 Drug Topics - January 2009 - Drug Topics - January 2009 (Page Cover1) Drug Topics - January 2009 - Drug Topics - January 2009 (Page Cover2) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 1) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 2) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 3) Drug Topics - January 2009 - Contents (Page 4) Drug Topics - January 2009 - Contents (Page 5) Drug Topics - January 2009 - Contents (Page 6) Drug Topics - January 2009 - Contents (Page 7) Drug Topics - January 2009 - Contents (Page 8) Drug Topics - January 2009 - Contents (Page 9) Drug Topics - January 2009 - Contents (Page 10) Drug Topics - January 2009 - Contents (Page 11) Drug Topics - January 2009 - Letters (Page 12) Drug Topics - January 2009 - Letters (Page H1) Drug Topics - January 2009 - Letters (Page H2) Drug Topics - January 2009 - Letters (Page H3) Drug Topics - January 2009 - Letters (Page H4) Drug Topics - January 2009 - Letters (Page H5) Drug Topics - January 2009 - Letters (Page H6) Drug Topics - January 2009 - Letters (Page H7) Drug Topics - January 2009 - Letters (Page H8) Drug Topics - January 2009 - Letters (Page 13) Drug Topics - January 2009 - Up Front (Page 14) Drug Topics - January 2009 - Up Front (Page 15) Drug Topics - January 2009 - Up Front (Page 16) Drug Topics - January 2009 - Up Front (Page 17) Drug Topics - January 2009 - Up Front in Depth (Page 18) Drug Topics - January 2009 - Up Front in Depth (Page 19) Drug Topics - January 2009 - Community Practice (Page 20) Drug Topics - January 2009 - Community Practice (Page 20a) Drug Topics - January 2009 - Community Practice (Page 20b) Drug Topics - January 2009 - Community Practice (Page 21) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 22) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 23) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 24) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 25) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 26) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 27) Drug Topics - January 2009 - OTC (Page 28) Drug Topics - January 2009 - OTC (Page 29) Drug Topics - January 2009 - OTC (Page 30) Drug Topics - January 2009 - OTC (Page 31) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 32) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 33) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 34) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 35) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 36) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 37) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 38) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 39) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 40) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 41) Drug Topics - January 2009 - New Products (Page 42) Drug Topics - January 2009 - New Products (Page 43) Drug Topics - January 2009 - New Products (Page 44) Drug Topics - January 2009 - New Products (Page 45) Drug Topics - January 2009 - New Products (Page 46) Drug Topics - January 2009 - New Products (Page 47) Drug Topics - January 2009 - Viewpoint (Page 48) Drug Topics - January 2009 - Viewpoint (Page Cover3) Drug Topics - January 2009 - Viewpoint (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.